Sophie Neugebauer
Jena, TH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Artificial Liver Support Effectively Removes Immunosuppressive Bile Acids From Circulation in Patients With Severe Liver Failure: A Proof of Concept Study.
Journal: Critical care explorations
Published: June 06, 2026
Correlation of brain injury biomarkers with brain dysfunction, brain injury, and outcomes in critically ill patients: a post hoc exploratory analysis.
Journal: Infection
Published: March 06, 2026
Loss of TGR5-activating bile acids is associated with disease activity in inflammatory bowel disease.
Journal: Scientific reports
Published: February 05, 2026
Metabolic Profiling Identifies 1-MetHis and 3-IPA as Potential Diagnostic Biomarkers for Patients With Acute and Chronic Heart Failure With Reduced Ejection Fraction.
Journal: Circulation. Heart failure
Published: January 05, 2024
Quantification of Bile Acids in Cerebrospinal Fluid: Results of an Observational Trial.
Journal: Biomedicines
Published: September 17, 2023
Serum Metabolome Signatures Characterizing Co-Infection of Plasmodium falciparum and HBV in Pregnant Women.
Journal: Diseases (Basel, Switzerland)
Published: May 17, 2023
Immunosuppressive effects of circulating bile acids in human endotoxemia and septic shock: patients with liver failure are at risk.
Journal: Critical care (London, England)
Published: May 16, 2023
Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
Journal: Intensive care medicine
Published: March 18, 2022
RIPK3 promoter hypermethylation in hepatocytes protects from bile acid-induced inflammation and necroptosis.
Journal: Cell death & disease
Published: January 31, 2022
Last Updated: 09/26/2026